Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis

被引：0
|
作者：
Amelia E. B. Moore
Glen M. Blake
Kathleen A. Taylor
Valerie A. Ruff
Asad E. Rana
Xiaohai Wan
Ignac Fogelman
机构：
[1] King’s College London School of Medicine,Department of Nuclear Medicine, Borough Wing; Guy’s Hospital
[2] Eli Lilly and Company and/or one of its subsidiaries,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Teriparatide; Tc-MDP bone scan; Bone turnover markers; Bone remodelling; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 336
页数：10
相关论文
共 50 条
  • [21] Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic Acid Treatment in a Patient with Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures
    Treurniet, Sanne
    Bevers, Melissa S. A. M.
    Wyers, Caroline E. E.
    Micha, Dimitra
    Teunissen, Bernd P. P.
    Elting, Mariet W. W.
    van den Bergh, Joop P. P.
    Eekhoff, Elisabeth M. W.
    CALCIFIED TISSUE INTERNATIONAL, 2023, 112 (05) : 621 - 627
  • [22] The role of DXA bone density scans in the diagnosis and treatment of osteoporosis
    Blake, Glen M.
    Fogelman, Ignac
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (982) : 509 - 517
  • [23] BONE MINERAL DENSITY AND BONE TURNOVER MARKERS AFTER ONE-YEAR TERIPARATIDE TREATMENT IN KOREAN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Oh, H.
    Choi, W.
    Choi, H.
    Kim, J.
    Lim, S.
    Joo, I.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 183 - 184
  • [24] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    A. Blumsohn
    F. Marin
    T. Nickelsen
    K. Brixen
    G. Sigurdsson
    J. González de la Vera
    S. Boonen
    S. Liu-Léage
    C. Barker
    R. Eastell
    Osteoporosis International, 2011, 22 : 1935 - 1946
  • [25] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    Blumsohn, A.
    Marin, F.
    Nickelsen, T.
    Brixen, K.
    Sigurdsson, G.
    Gonzalez de la Vera, J.
    Boonen, S.
    Liu-Leage, S.
    Barker, C.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1935 - 1946
  • [26] Changes in bone resorption markers during osteoporosis treatment with oral bisphosphonates
    Eckman, D. A.
    Derikx, H. J. G. M.
    Bultink, I. E. M.
    Van Zanten, A. P.
    Lems, W. F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S191 - S191
  • [27] Malignant Myeloma in a Patient After Treatment for Osteoporosis with Teriparatide; a Rare Coincidence
    Forslund, Terje
    Koski, Anna-Mari
    Koistinen, Arvo
    Sikio, Anu
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2008, 1 : 119 - 122
  • [28] Effects of discontinuation of teriparatide treatment on cortical bone in postmenopausal women with osteoporosis.
    Bogado, CE
    Mango, A
    Sato, M
    Zanchetta, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S54 - S54
  • [29] The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis
    Luchavova, Maria
    Zikan, Vit
    Michalska, Dana
    Raska, Ivan, Jr.
    Kubena, Ales A.
    Stepan, Jan J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) : 643 - 648
  • [30] Combined treatment of vitamin K and teriparatide on bone metabolism and biomechanics in rats with osteoporosis
    Huang, Youqing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 315 - 319
12345